secwatch / observer
8-K filed November 21, 2023, 6:59 PM ET ticker NRXP CIK 0001719406
other material confidence high sentiment negative materiality 0.60

NRX Pharmaceuticals, Inc. (NRXP): auditor change — NRX Pharmaceuticals dismisses KPMG as auditor, appoints Salberg & Company

NRX Pharmaceuticals, Inc.

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

NRX Pharmaceuticals, Inc. engaged Salberg & Company, P.A. as its auditor.

Action
engagement
Auditor
Salberg & Company, P.A.
Exact text from the filing
On November 17, 2023, the Board engaged Salberg & Company, P.A. (“Salberg”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, effective immediately.
View on SEC.gov
Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

NRX Pharmaceuticals, Inc. dismissed KPMG LLP as its auditor.

Action
dismissal
Auditor
KPMG LLP
Successor
Salberg & Company, P.A.
Exact text from the filing
On November 15, 2023, the Board of Directors (the “Board”) of NRx Pharmaceuticals, Inc. (the “Company”) approved the dismissal of KPMG LLP (“KPMG”) as the Company’s independent registered public accounting firm, effective immediately.
View on SEC.gov

Browse all auditor changes →

NRX Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-23-120428
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.